
Merck Serono is looking to expand further into personalised medicine as the company enters into an agreement with Illumina to …

Johnson & Johnson has been offered $4.15 billion by private equity firm The Carlyle Group to buy its Ortho-Clinical Diagnostics …

Roche has acquired Boston-based Constitution Medical Investors in order to buy into its haematology testing system. The cancer drug specialist …

Roche has said it intends to invest more than €200 million ($260m) in the construction of a new production plant …

Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …

Roche has conceded defeat in its bid to buy Illumina, after shareholders of the diagnostics firm blocked the takeover – …

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …
GlaxoSmithKline has signed a deal to develop new tests with Enigma Diagnostics, extending a 2009 agreement with the Salisbury-based company. …
Swiss drugmaker Roche is planning to invest $180 million and boost staff at its diagnostics subsidiary Ventana Medical Systems, as …

Roche has added to its portfolio of diagnostics products by acquiring US company BioImagene. The privately held Californian company specialises …
Roche has acquired insulin delivery specialist company Medingo to consolidate its presence in the diabetes care market. Medingo, formerly a …
AstraZeneca and cancer diagnostics specialist Dako Denmark are to develop companion diagnostics for a number of the pharma company’s oncology …

In this week’s roundup: Roche answers cancer testing questions, Novartis uses SMS in fight against malaria, UCB goes to Facebook …